Speciality: Oncology
Description:
Dr. Sushant Mittal kicked off the insightful session titled "CNS Clarity from Day One: Rethinking Early Diagnostic Strategies", joined by esteemed panelists Dr. Tarachand Gupta and Dr. Randeep Singh. The discussion opened with a strong emphasis on the clinical importance of early evaluation for central nervous system (CNS) involvement, especially in complex or aggressive disease presentations. Dr. Mittal highlighted how delays in CNS assessment can result in mismanagement or missed therapeutic windows, setting the tone for a thought-provoking exchange. Dr. Gupta and Dr. Singh added their expertise from neurology and oncology perspectives, offering valuable multidisciplinary insights.
The session explored how CNS evaluation at the time of initial diagnosis is gaining traction in clinical protocols. With advancements in neuroimaging, cerebrospinal fluid analysis, and molecular biomarkers, early detection of CNS disease has become more achievable and actionable. The panel discussed real-world challenges in integrating these strategies, including resource constraints and variability in presentation. Emphasis was placed on identifying high-risk patients early - particularly in oncology and infectious disease contexts - where CNS involvement can significantly affect prognosis and treatment pathways. The conversation also touched on the need for standardized screening protocols and decision-making frameworks that support clinicians across specialties.
Thank you to all who joined this informative session. Your engagement and curiosity continue to drive these meaningful conversations forward. Special thanks to Dr. Sushant Mittal, Dr. Tarachand Gupta, and Dr. Randeep Singh for sharing their expertise. Keep following us for more sessions focused on innovation, interdisciplinary practice, and cutting-edge strategies in healthcare. Together, we’re reshaping how diseases are diagnosed and managed - starting from day one.
See More Webinars @ Hidoc Webinars
1.
Why breast cancer survivors don't take their medicine, and what can be done about it.
2.
A novel test shows promise for finding cervical adenocarcinoma, which is difficult to find.
3.
Accuracy of Skin Cancer Diagnosis Varies by Physician, Exam Method
4.
The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.
5.
Will a Mindfulness-Based Treatment for Depression Increase Recovery Rates?
1.
Oncology Treatment: Innovations, Education, and Clinical Practice Insights
2.
Targeting Cancer Stem Cells in Solid Tumors: Mechanisms, Clinical Implications, and Therapeutic Advances
3.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
4.
Respiratory Ramifications of Systemic Disease: A Comprehensive Review
5.
Deep Learning Fluorescence Imaging for Oral Cancer Surgery: In Silico Depth Quantification
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
2.
Clinical Excellence in Hematology
3.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
5.
Diagnosis and Management in Hematology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation